Evaluation of Epic® label-free technology to quantify functional recombinant hemagglutinin

BACKGROUND: Alternative methods are being sought to measure the potency of influenza vaccines. Label-free technologies that do not require the use of hemagglutinin (HA)-specific antisera are particularly attractive as the preparation of antiserum delays availability of potency reagents. The objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lianlian, Eichelberger, Maryna C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359790/
https://www.ncbi.nlm.nih.gov/pubmed/25774096
http://dx.doi.org/10.1186/s12575-015-0019-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359790/
https://www.ncbi.nlm.nih.gov/pubmed/25774096
http://dx.doi.org/10.1186/s12575-015-0019-5

Ejemplares similares